ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,234,445, issued on Feb. 25, was assigned to Calysta Inc. (Menlo Park, Calif.).
"Glycogen-null methanotrophs and uses thereof" was invented by Renee M. Saville (Mountain View, Calif.), Joshua A. Silverman (Los Altos Hills, Calif.), Vincent Tang (Menlo Park, Calif.), Eric G. Luning (Sunnyvale, Calif.), Paloma Rueda (Menlo Park, Calif.), Megan Hsi (Menlo Park, Calif.) and Yelena Stegantseva (Menlo Park, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methanotrophic bacteria that are modified to produce less glycogen, and methods of using the modified methanotrophic bacteria to produce a desired product, such as protein...